Management of Hyperglycemia in Hospitalized Adult Patients in Non-Critical Care Settings: An Endocrine Society Clinical Practice Guideline
Open accessThe DOI matches its Crossref record; 132 of the 135 references it cites were found in a registry or an index.
Abstract
Background: Adult patients with diabetes or newly recognized hyperglycemia account for over 30% of noncritically ill hospitalized patients. These patients are at increased risk for adverse clinical outcomes in the absence of defined approaches to glycemic management. Objective: To review and update the 2012 Management of Hyperglycemia in Hospitalized Patients in Non-Critical Care Settings: An Endocrine Society Clinical Practice Guideline and to address emerging areas specific to the target population of noncritically ill hospitalized patients with diabetes or newly recognized or stress-induced hyperglycemia. Methods: A multidisciplinary panel of clinician experts, together with a patient representative and experts in systematic reviews and guideline development, identified and prioritized 10 clinical questions related to inpatient management of patients with diabetes and/or hyperglycemia. The systematic reviews queried electronic databases for studies relevant to the selected questions. The Grading of Recommendations Assessment, Development and Evaluation (GRADE) methodology was used to assess the certainty of evidence and make recommendations. Results: The panel agreed on 10 frequently encountered areas specific to glycemic management in the hospital for which 15 recommendations were made. The guideline includes conditional recommendations for hospital use of emerging diabetes technologies including continuous glucose monitoring and insulin pump therapy; insulin regimens for prandial insulin dosing, glucocorticoid, and enteral nutrition–associated hyperglycemia; and use of noninsulin therapies. Recommendations were also made for issues relating to preoperative glycemic measures, appropriate use of correctional insulin, and diabetes self-management education in the hospital. A conditional recommendation was made against preoperative use of caloric beverages in patients with diabetes. Conclusion: The recommendations are based on the consideration of important outcomes, practicality, feasibility, and patient values and preferences. These recommendations can be used to inform system improvement and clinical practice for this frequently encountered inpatient population.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, the intensively controlled group had increased mortality and higher rates of hypoglycemia.95,97”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [97]
In the citing paper
“Studies have been published assessing the effectiveness of this approach, which may ultimately lead to the approved use of CGM for monitoring hospitalized individuals (277,286-295).”
From 7. Diabetes Technology: Standards of Care in Diabetes—2025 (2025) · cites this paper as [288]
Citations
Cites
Clinical Practice Guidelines We Can Trust
Committee on Standards for Developing Trustworthy Clinical Practice Guidelines, Board on Health Care Services, & Institute of Medicine (2011) · National Academies Press eBooks · doi:10.17226/13058 · Cited by 3,081
Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes
Umpierrez, G. E., Isaacs, S. D., Bazargan, N., You, X., Thaler, L. M., & Kitabchi, A. E. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.3.8341 · Cited by 2,195
Self-citationMoghissi, E. S., Korytkowski, M. T., DiNardo, M., Einhorn, D., Hellman, R., Hirsch, I. B., Inzucchi, S. E., Ismail-Beigi, F., Kirkman, M. S., & Umpierrez, G. E. (2009) · Diabetes Care · doi:10.2337/dc09-9029 · Cited by 1,444
Self-citationAndrews, J., Guyatt, G., Oxman, A. D., Alderson, P., Dahm, P., Falck-Ytter, Y., Nasser, M., Meerpohl, J., Post, P. N., Kunz, R., et al. (2013) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2012.03.013 · Cited by 1,416 · cited 1×
“During a series of video conferences, the GDP judged the balance of benefits and harms, in addition to the other EtD criteria, to determine the direction and strength of the recommendation (Table 4 and 5) (133-136).”
BackgroundAlonso-Coello, P., Schünemann, H. J., Moberg, J., Brignardello-Petersen, R., Akl, E. A., Davoli, M., Treweek, S., Mustafa, R. A., Rada, G., Rosenbaum, S., et al. (2016) · BMJ · doi:10.1136/bmj.i2016 · Cited by 1,317
Umpierrez, G. E., Hellman, R., Korytkowski, M. T., Kosiborod, M., Maynard, G. A., Montori, V. M., Seley, J. J., & Van den Berghe, G. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2098 · Cited by 1,126 · cited 5×
“Should basal or BBI vs NPH insulin be used for adults hospitalized for noncritical illness receiving enteral nutrition with diabetesspecific and nonspecific formulations? Background Hyperglycemia frequently occurs in hospitalized patients receiving enteral nutrition and is associated with a higher risk of complication…”
BackgroundInfluentialSelf-citation9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes—2021
American Diabetes Association (2021) · Diabetes Care · doi:10.2337/dc21-s009 · Cited by 972
Schünemann, H. J., Cushman, M., Burnett, A. E., Kahn, S. R., Beyer-Westendorf, J., Spencer, F. A., Rezende, S. M., Zakai, N. A., Bauer, K. A., Dentali, F., et al. (2018) · Blood Advances · doi:10.1182/bloodadvances.2018022954 · Cited by 819 · cited 4×
“M. Hassan Murad, MD Mayo Clinic Evidence-Based Practice Center: Rochester, MN, USA Expertise: Clinical practice guideline methodology Disclosures (2019-2022): • Society for Vascular Surgery: Methodology Consultant • American Society of Hematology: Methodology Consultant • CHEST: Methodology Consultant • World Health O…”
BackgroundInfluentialAlonso-Coello, P., Oxman, A. D., Moberg, J., Brignardello-Petersen, R., Akl, E. A., Davoli, M., Treweek, S., Mustafa, R. A., Vandvik, P. O., Meerpohl, J., et al. (2016) · BMJ · doi:10.1136/bmj.i2089 · Cited by 814
Umpierrez, G. E., Smiley, D., Jacobs, S., Peng, L., Temponi, A., Mulligan, P., Umpierrez, D., Newton, C., Olson, D., & Rizzo, M. (2011) · Diabetes Care · doi:10.2337/dc10-1407 · Cited by 720
Self-citationUmpierrez, G. E., Smiley, D., Zisman, A., Prieto, L. M., Palacio, A., Ceron, M., Puig, A., & Mejia, R. (2007) · Diabetes Care · doi:10.2337/dc07-0295 · Cited by 671
Self-citationPowers, M. A., Bardsley, J. K., Cypress, M., Funnell, M. M., Harms, D., Hess-Fischl, A., Hooks, B., Isaacs, D., Mandel, E. D., Maryniuk, M. D., et al. (2020) · Diabetes Care · doi:10.2337/dci20-0023 · Cited by 500
8. Pharmacologic Approaches to Glycemic Treatment
American Diabetes Association (2017) · Diabetes Care · doi:10.2337/dc17-s011 · Cited by 458
Long-term Glycemic Control and Postoperative Infectious Complications
Dronge, A. S. (2006) · Archives of Surgery · doi:10.1001/archsurg.141.4.375 · Cited by 374
Sato, H., Carvalho, G., Sato, T., Lattermann, R., Matsukawa, T., & Schricker, T. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0135 · Cited by 333
Swiglo, B. A., Murad, M. H., Schünemann, H. J., Kunz, R., Vigersky, R. A., Guyatt, G. H., & Montori, V. M. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1907 · Cited by 302 · cited 1×
“Methods of Development of Evidence-based Clinical Practice Guidelines This guideline was developed using the GRADE (Grading of Recommendations Assessment, Development and Evaluation) methodology (128).”
MethodSelf-citationUmpierrez, G., Cardona, S., Pasquel, F., Jacobs, S., Peng, L., Unigwe, M., Newton, C. A., Smiley-Byrd, D., Vellanki, P., Halkos, M., et al. (2015) · Diabetes Care · doi:10.2337/dc15-0303 · Cited by 281 · cited 1×
“Both diabetes and hyperglycemia in the hospital are associated with prolonged hospital stay, increased incidence of complications, and disability after hospital discharge (5, 6).”
BackgroundSelf-citationPrevalence and predictors of corticosteroid-related hyperglycemia in hospitalized patients
Donihi, A. C., Raval, D., Saul, M., Korytkowski, M. T., & DeVita, M. A. (2006) · Endocrine Practice · doi:10.4158/ep.12.4.358 · Cited by 246 · cited 11×
“Recommendation 2.1 In adult patients who are hospitalized for noncritical illness and experience hyperglycemia while receiving GCs, we suggest glycemic management with either NPH-based insulin or BBI regimens.”
BackgroundInfluentialSelf-citationAn Effective Model of Diabetes Care and Education: The ADCES7 Self-Care Behaviors™
Association of Diabetes Care and Education Specialists, & Kolb, L. (2021) · The Science of Diabetes Self-Management and Care · doi:10.1177/0145721720978154 · Cited by 246
Diabetes Mellitus, Hemoglobin A1C, and the Incidence of Total Joint Arthroplasty Infection
Iorio, R., Williams, K. M., Marcantonio, A. J., Specht, L. M., Tilzey, J. F., & Healy, W. L. (2012) · The Journal of Arthroplasty · doi:10.1016/j.arth.2011.09.013 · Cited by 235
Underwood, P., Askari, R., Hurwitz, S., Chamarthi, B., & Garg, R. (2014) · Diabetes Care · doi:10.2337/dc13-1929 · Cited by 231 · cited 2×
“The effects of race and sex were evaluated in only 2 studies (90, 97) with neutral results.”
BackgroundGlucocorticoid-Induced Diabetes Mellitus: An Important but Overlooked Problem
Suh, S., & Park, M. K. (2017) · Endocrinology and Metabolism · doi:10.3803/enm.2017.32.2.180 · Cited by 227 · cited 1×
“Barriers to addressing GC-associated hyperglycemia may be bridged by establishing protocols and guidelines that outline best practices for achieving and maintaining glycemic control, such as administration of NPH at the same time as intermediate-acting GCs, such as prednisone or methylprednisolone (36-38).”
BackgroundUmpierrez, G. E., Smiley, D., Hermayer, K., Khan, A., Olson, D. E., Newton, C., Jacobs, S., Rizzo, M., Peng, L., Reyes, D., et al. (2013) · Diabetes Care · doi:10.2337/dc12-1988 · Cited by 222
Self-citationInpatient glucose control: a glycemic survey of 126 U.S. hospitals
Cook, C. B., Kongable, G. L., Potter, D. J., Abad, V. J., Leija, D. E., & Anderson, M. (2009) · Journal of Hospital Medicine · doi:10.1002/jhm.533 · Cited by 213 · cited 1×
“Another 12% to 25% of hospitalized patients experience hyperglycemia, defined as blood glucose (BG) > 140 mg/dL (2-4).”
BackgroundHealy, S. J., Black, D., Harris, C., Lorenz, A., & Dungan, K. M. (2013) · Diabetes Care · doi:10.2337/dc13-0108 · Cited by 209 · cited 3×
“88)] with an estimated 43 fewer hospital readmissions per 1000 patients (95% CI –61 to –18); very low level of certainty] when inpatient diabetes education was part of a comprehensive diabetes discharge-planning process (49-51).”
BackgroundO'Sullivan, C. J., Hynes, N., Mahendran, B., Andrews, E. J., Avalos, G., Tawfik, S., Lowery, A., & Sultan, S. (2006) · European Journal of Vascular and Endovascular Surgery · doi:10.1016/j.ejvs.2006.01.011 · Cited by 204 · cited 3×
“33); very low level of certainty] (60, 61, 64, 65, 67, 68, 72, 73, 85-87, 89, 91, 92) were also observed.”
Halkos, M. E., Lattouf, O. M., Puskas, J. D., Kilgo, P., Cooper, W. A., Morris, C. D., Guyton, R. A., & Thourani, V. H. (2008) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2008.06.078 · Cited by 204 · cited 5×
“78); very low level of certainty] (60, 61, 6468, 72, 86-88), postoperative renal failure [12 observational (non-RCT) studies: RR 0.”
BackgroundInfluentialGlycemic Control in Non-Critically Ill Hospitalized Patients: A Systematic Review and Meta-Analysis
Murad, M. H., Coburn, J. A., Coto-Yglesias, F., Dzyubak, S., Hazem, A., Lane, M. A., Prokop, L. J., & Montori, V. M. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2100 · Cited by 192 · cited 2×
“Effective management of hyperglycemia in patients on enteral nutrition decreases adverse outcomes but also increases the risk of hypoglycemia (4, 99).”
BackgroundSelf-citationAdjust to Target in Type 2 Diabetes
Bergenstal, R. M., Johnson, M., Powers, M. A., Wynne, A., Vlajnic, A., Hollander, P., & Rendell, M. (2008) · Diabetes Care · doi:10.2337/dc07-2137 · Cited by 181 · cited 1×
“This method calculates doses of premeal rapid- or shortacting insulin based on the anticipated CHO content of the food to be consumed (114), potentially offering more flexibility in insulin dosing and improved postprandial glycemic excursions when compared to fixed premeal dosing (115).”
MethodGalindo, R. J., Migdal, A. L., Davis, G. M., Urrutia, M. A., Albury, B., Zambrano, C., Vellanki, P., Pasquel, F. J., Fayfman, M., Peng, L., et al. (2020) · Diabetes Care · doi:10.2337/dc19-2073 · Cited by 181 · cited 2×
“12 mg/dL); moderate level of certainty] (12-14, 16-20).”
MethodSelf-citationChrastil, J., Anderson, M. B., Stevens, V., Anand, R., Peters, C. L., & Pelt, C. E. (2015) · The Journal of Arthroplasty · doi:10.1016/j.arth.2015.01.040 · Cited by 180 · cited 1×
“Other evidence to decision criteria and considerations Among the studies that evaluated the effect of preoperative BG concentrations on postoperative outcomes (83, 93-96), only 2 provided data on BG concentrations on the day of surgery (95, 96).”
BackgroundAdams, A. L., Paxton, E. W., Wang, J. Q., Johnson, E. S., Bayliss, E. A., Ferrara, A., Nakasato, C., Bini, S. A., & Namba, R. S. (2013) · The Journal of Bone and Joint Surgery · doi:10.2106/jbjs.l.00109 · Cited by 167
Umpierrez, G. E., Gianchandani, R., Smiley, D., Jacobs, S., Wesorick, D. H., Newton, C., Farrokhi, F., Peng, L., Reyes, D., Lathkar-Pradhan, S., et al. (2013) · Diabetes Care · doi:10.2337/dc13-0277 · Cited by 166 · cited 1×
“Benefits and harms The systematic review identified 5 RCTs that compared the effects of a noninsulin agent without scheduled insulin in comparison to an insulin-only approach (11, 105-109).”
BackgroundSelf-citationGalindo, R. J., Aleppo, G., Klonoff, D. C., Spanakis, E. K., Agarwal, S., Vellanki, P., Olson, D. E., Umpierrez, G. E., Davis, G. M., & Pasquel, F. J. (2020) · Journal of Diabetes Science and Technology · doi:10.1177/1932296820932903 · Cited by 155 · cited 1×
“Overall, the panel determined that the feasibility of introducing CGM for noncritically ill patients at high risk for hypoglycemia will vary by institution, and if implemented, a protocol for guiding the process is necessary for success (Table 2) (23, 24).”
BackgroundSelf-citationSingh, L. G., Satyarengga, M., Marcano, I., Scott, W. H., Pinault, L. F., Feng, Z., Sorkin, J. D., Umpierrez, G. E., & Spanakis, E. K. (2020) · Diabetes Care · doi:10.2337/dc20-0840 · Cited by 154 · cited 4×
“However, several reported studies included minority populations in underserved areas, many of whom had chronic kidney disease stages 3 to 5, demonstrating the feasibility of CGM in high-risk populations (15, 17).”
BackgroundMethodInfluentialSelf-citationKorytkowski, M. T., Salata, R. J., Koerbel, G. L., Selzer, F., Karslioglu, E., Idriss, A. M., Lee, K. K. W., Moser, A. J., & Toledo, F. G. S. (2009) · Diabetes Care · doi:10.2337/dc08-1436 · Cited by 149 · cited 2×
“Benefits and harms The systematic review identified 2 systematic reviews, 1 RCT, and 3 non-RCTs that address this question (11, 98, 101-103).”
BackgroundSelf-citationPathways to Quality Inpatient Management of Hyperglycemia and Diabetes: A Call to Action
Draznin, B., Gilden, J., Golden, S. H., Inzucchi, S. E., & for the PRIDE investigators (2013) · Diabetes Care · doi:10.2337/dc12-2508 · Cited by 145
Glycemic control and infections in patients with diabetes undergoing noncardiac surgery
King, J. T., Goulet, J. L., Perkal, M. F., & Rosenthal, R. A. (2011) · Annals of Surgery · doi:10.1097/sla.0b013e3181f9bb3a · Cited by 142
Closed-loop insulin delivery in inpatients with type 2 diabetes: a randomised, parallel-group trial
Thabit, H., Hartnell, S., Allen, J. M., Lake, A., Wilinska, M. E., Ruan, Y., Evans, M. L., Coll, A. P., & Hovorka, R. (2017) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(16)30280-7 · Cited by 137 · cited 2×
“12 mg/dL); moderate level of certainty] (12-14, 16-20).”
MethodHan, H.-S., & Kang, S.-B. (2013) · Clinics in Orthopedic Surgery · doi:10.4055/cios.2013.5.2.118 · Cited by 135
Hwang, J. S., Kim, S. J., Bamne, A. B., Na, Y. G., & Kim, T. K. (2015) · Clinical Orthopaedics & Related Research · doi:10.1007/s11999-014-4056-1 · Cited by 134 · cited 1×
“Other evidence to decision criteria and considerations Among the studies that evaluated the effect of preoperative BG concentrations on postoperative outcomes (83, 93-96), only 2 provided data on BG concentrations on the day of surgery (95, 96).”
BackgroundFortmann, A. L., Spierling Bagsic, S. R., Talavera, L., Garcia, I. M., Sandoval, H., Hottinger, A., & Philis-Tsimikas, A. (2020) · Diabetes Care · doi:10.2337/dc20-1016 · Cited by 121 · cited 2×
“12 mg/dL); moderate level of certainty] (12-14, 16-20).”
BackgroundA practical guide for the management of steroid induced hyperglycaemia in the hospital
Aberer, F., Hochfellner, D. A., Sourij, H., & Mader, J. K. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10102154 · Cited by 110 · cited 1×
“• The purpose of this guideline was not to provide comprehensive strategies for selecting doses of insulin treatment of GC-induced hyperglycemia; however, the reader can refer to recently published review papers (39-41) for suggestions regarding insulin dosing adjustments for upward or downward titrations of GC therap…”
BackgroundThe high incidence of steroid-induced hyperglycaemia in hospital
Fong, A. C., & Cheung, N. W. (2013) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2012.12.023 · Cited by 109
Steroid-induced hyperglycemia: An underdiagnosed problem or clinical inertia? A narrative review
Bonaventura, A., & Montecucco, F. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.03.006 · Cited by 108 · cited 1×
“Barriers to addressing GC-associated hyperglycemia may be bridged by establishing protocols and guidelines that outline best practices for achieving and maintaining glycemic control, such as administration of NPH at the same time as intermediate-acting GCs, such as prednisone or methylprednisolone (36-38).”
BackgroundHypoglycemia in patient with type 2 diabetes treated with insulin: it can happen
Heller, S. R., Peyrot, M., Oates, S. K., & Taylor, A. D. (2020) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2020-001194 · Cited by 101 · cited 1×
“The baseline risk of hypoglycemia may be similar in insulintreated patients with T2D to what occurs with type 1 diabetes (T1D), suggesting that hospitalized patients with T1D would derive similar benefits with CGM use (21).”
BackgroundGómez, A. M., Umpierrez, G. E., Muñoz, O. M., Herrera, F., Rubio, C., Aschner, P., & Buendia, R. (2016) · Journal of Diabetes Science and Technology · doi:10.1177/1932296815602905 · Cited by 97 · cited 3×
“12 mg/dL); moderate level of certainty] (12-14, 16-20).”
BackgroundMethodSelf-citationKo, S. ‐., Song, K. ‐., Kim, S. ‐., Lee, J. ‐., Kim, J. ‐., Shin, J. ‐., Cho, Y. ‐., Park, Y. ‐., Jeong, J. ‐., Yoon, K. ‐., et al. (2007) · Diabetic Medicine · doi:10.1111/j.1464-5491.2007.02013.x · Cited by 94 · cited 1×
“Benefits and harms The systematic review identified 4 RCTs and 6 non-RCTs to address this question (11, 45-54).”
BackgroundWexler, D. J., Beauharnais, C. C., Regan, S., Nathan, D. M., Cagliero, E., & Larkin, M. E. (2012) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2012.09.016 · Cited by 89 · cited 2×
“Benefits and harms The systematic review identified 4 RCTs and 6 non-RCTs to address this question (11, 45-54).”
BackgroundFayfman, M., Galindo, R. J., Rubin, D. J., Mize, D. L., Anzola, I., Urrutia, M. A., Ramos, C., Pasquel, F. J., Haw, J. S., Vellanki, P., et al. (2019) · Diabetes Care · doi:10.2337/dc18-1760 · Cited by 85 · cited 1×
“Benefits and harms The systematic review identified 5 RCTs that compared the effects of a noninsulin agent without scheduled insulin in comparison to an insulin-only approach (11, 105-109).”
BackgroundSelf-citationBurt, M. G., Roberts, G. W., Aguilar-Loza, N. R., & Stranks, S. N. (2013) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2012.0282 · Cited by 83
Cook, C. B., Beer, K. A., Seifert, K. M., Boyle, M. E., Mackey, P. A., & Castro, J. C. (2012) · Journal of Diabetes Science and Technology · doi:10.1177/193229681200600502 · Cited by 80 · cited 4×
“Benefits and harms The systematic review identified 2 non-RCTs to address this question (11, 42, 43).”
BackgroundInfluentialVellanki, P., Rasouli, N., Baldwin, D., Alexanian, S., Anzola, I., Urrutia, M., Cardona, S., Peng, L., Pasquel, F. J., Umpierrez, G. E., et al. (2019) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13587 · Cited by 80 · cited 1×
“Benefits and harms The systematic review identified 5 RCTs that compared the effects of a noninsulin agent without scheduled insulin in comparison to an insulin-only approach (11, 105-109).”
BackgroundSelf-citationKufeldt, J., Kovarova, M., Adolph, M., Staiger, H., Bamberg, M., Häring, H.-U., Fritsche, A., & Peter, A. (2018) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-0043-112653 · Cited by 80 · cited 2×
“Recognizing the magnitude of the problem and the continued variability that persists in managing hospitalized patients with diabetes and/or newly recognized hyperglycemia, the Endocrine Society convened a Guideline Development Panel (GDP) comprised of healthcare professionals involved in inpatient diabetes care to rev…”
BackgroundSafety and efficacy of saxagliptin for glycemic control in non-critically ill hospitalized patients
Garg, R., Schuman, B., Hurwitz, S., Metzger, C., & Bhandari, S. (2017) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2017-000394 · Cited by 79 · cited 1×
“Benefits and harms The systematic review identified 5 RCTs that compared the effects of a noninsulin agent without scheduled insulin in comparison to an insulin-only approach (11, 105-109).”
BackgroundWalid, M. S., Newman, B. F., Yelverton, J. C., Nutter, J. P., Ajjan, M., & Robinson, J. S. (2010) · Journal of Hospital Medicine · doi:10.1002/jhm.541 · Cited by 75 · cited 2×
“Preoperative glycemic measures and presence of diabetes were significant determinants of total cost of hospital care (97).”
BackgroundKnapik, P., Cieśla, D., Filipiak, K., Knapik, M., & Zembala, M. (2011) · European Journal of Cardio-Thoracic Surgery · doi:10.1016/j.ejcts.2010.07.037 · Cited by 67
Seisa, M. O., Saadi, S., Nayfeh, T., Muthusamy, K., Shah, S. H., Firwana, M., Hasan, B., Jawaid, T., Abd-Rabu, R., Korytkowski, M. T., et al. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac277 · Cited by 65
Self-citationHsia, E., Seggelke, S. A., Gibbs, J., Rasouli, N., & Draznin, B. (2011) · Nutrition in Clinical Practice · doi:10.1177/0884533611420727 · Cited by 62
An Inpatient Diabetes Educator's Impact on Length of Hospital Stay
Feddersen, E., & Lockwood, D. H. (1994) · The Diabetes Educator · doi:10.1177/014572179402000207 · Cited by 60 · cited 17×
“Justification for the recommendation The panel based its recommendation on low-certainty evidence demonstrating similar glycemic outcomes for mean BG, hyperglycemia, hypoglycemia, and hospital LOS with NPHand BBI-based regimens for patients with GC-associated hyperglycemia in the hospital.”
BackgroundInfluentialAidar, R. G., Salil, G., Sundae, S., Limin, P., & Umpierrez, G. E. (2013) · Endocrine Practice · doi:10.4158/ep12256.or · Cited by 59 · cited 1×
“Similar findings were observed with observational (non-RCT) studies (125-127).”
ResultSelf-citationDiNardo, M. M., Donihi, A. C., Forte, P. J., Gieraltowski, L. B., & Korytkowski, M. T. (2011) · Endocrine Practice · doi:10.4158/ep10316.or · Cited by 59
Self-citationVan Steen, S., Rijkenberg, S., Limpens, J., Van der Voort, P., Hermanides, J., & DeVries, J. (2017) · Sensors · doi:10.3390/s17010146 · Cited by 59 · cited 2×
“Blood Adv, 2018; 2(22) © by The American Society of Hematology (136).”
BackgroundFaulds, E. R., Jones, L., McNett, M., Smetana, K. S., May, C. C., Sumner, L., Buschur, E., Exline, M., Ringel, M. D., & Dungan, K. (2021) · Endocrine Practice · doi:10.1016/j.eprac.2021.01.011 · Cited by 58 · cited 1×
“Overall, the panel determined that the feasibility of introducing CGM for noncritically ill patients at high risk for hypoglycemia will vary by institution, and if implemented, a protocol for guiding the process is necessary for success (Table 2) (23, 24).”
BackgroundDiabetes Transitional Care from Inpatient to Outpatient Setting: Pharmacist Discharge Counseling
Shah, M., Norwood, C. A., Farias, S., Ibrahim, S., Chong, P. H., & Fogelfeld, L. (2013) · Journal of Pharmacy Practice · doi:10.1177/0897190012451907 · Cited by 55 · cited 1×
“Benefits and harms The systematic review identified 4 RCTs and 6 non-RCTs to address this question (11, 45-54).”
BackgroundHospital insulin protocol aims for glucose control in glucocorticoid-induced hyperglycemia
Grommesh, B., Lausch, M. J., Vannelli, A. J., Mullen, D. M., Bergenstal, R. M., Richter, S. A., & Fish, L. H. (2016) · Endocrine Practice · doi:10.4158/ep15818.or · Cited by 52 · cited 2×
“In the 3 RCTs involving 148 patients comparing NPH added to a BBI regimen with BBI alone (28-30), the mean daily BG was 40.”
BackgroundVaz, E. C., Porfírio, G. J. M., Nunes, H. R. D. C., & Nunes-Nogueira, V. D. S. (2018) · Archives of Endocrinology and Metabolism · doi:10.20945/2359-3997000000045 · Cited by 52 · cited 1×
“Should carbohydrate counting for prandial insulin dosing vs no carbohydrate counting (other insulin-dosing regimen) be used for adults with diabetes hospitalized for noncritical illness? Background CC is a strategy used for calculating prandial doses of insulin often used by nonhospitalized patients with T1D or T2D re…”
MethodRadhakutty, A., & Burt, M. G. (2018) · European Journal of Endocrinology · doi:10.1530/eje-18-0315 · Cited by 50
Dhital, S. M., Shenker, Y., Meredith, M., & Davis, D. B. (2012) · Endocrine Practice · doi:10.4158/ep11371.or · Cited by 49 · cited 1×
“or an observational (non-RCT) study (33) whose design involved comparing NPH administered with prandial bolus vs basal bolus therapy.”
BackgroundGodshaw, B. M., Ojard, C. A., Adams, T. M., Chimento, G. F., Mohammed, A., & Waddell, B. S. (2018) · The Journal of Arthroplasty · doi:10.1016/j.arth.2018.02.071 · Cited by 48
Schaupp, L., Donsa, K., Neubauer, K. M., Mader, J. K., Aberer, F., Höll, B., Spat, S., Augustin, T., Beck, P., Pieber, T. R., et al. (2015) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2014.0343 · Cited by 47 · cited 4×
“12 mg/dL); moderate level of certainty] (12-14, 16-20).”
BackgroundMethodInfluentialDrincic, A. T., Knezevich, J. T., & Akkireddy, P. (2017) · Current Diabetes Reports · doi:10.1007/s11892-017-0882-3 · Cited by 47
Self-citationRuiz de Adana, M. S., Colomo, N., Maldonado-Araque, C., Fontalba, M. I., Linares, F., García-Torres, F., Fernández, R., Bautista, C., Olveira, G., de la Cruz, J. L., et al. (2015) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2015.09.015 · Cited by 45 · cited 5×
“12 mg/dL); moderate level of certainty] (12-14, 16-20).”
BackgroundMethodInfluentialTsuruta, R., Miyauchi, K., Yamamoto, T., Dohi, S., Tambara, K., Dohi, T., Inaba, H., Kuwaki, K., Daida, H., & Amano, A. (2011) · Journal of Cardiology · doi:10.1016/j.jjcc.2010.11.003 · Cited by 45 · cited 3×
“33); very low level of certainty] (60, 61, 64, 65, 67, 68, 72, 73, 85-87, 89, 91, 92) were also observed.”
BackgroundInsulin Pump Patient Characteristics and Glucose Control in the Hospitalized Setting
Kannan, S., Satra, A., Calogeras, E., Lock, P., & Lansang, M. C. (2014) · Journal of Diabetes Science and Technology · doi:10.1177/1932296814522809 · Cited by 45 · cited 3×
“Benefits and harms The systematic review identified 2 non-RCTs to address this question (11, 42, 43).”
BackgroundNyström, T., Holzmann, M. J., Eliasson, B., Kuhl, J., & Sartipy, U. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.05.054 · Cited by 43 · cited 21×
“A minority of patients with T1D were included, a single study recruited only patients with T1D (59), and many studies did not specify the type of diabetes.”
BackgroundInfluentialLakhani, O., Kumar, S., Tripathi, S., Desai, M., & Seth, C. (2017) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/ijem.ijem_226_17 · Cited by 43 · cited 1×
“In the 3 RCTs involving 148 patients comparing NPH added to a BBI regimen with BBI alone (28-30), the mean daily BG was 40.”
BackgroundSeggelke, S. A., Gibbs, J., & Draznin, B. (2011) · Journal of Hospital Medicine · doi:10.1002/jhm.874 · Cited by 42 · cited 1×
“In the 3 RCTs involving 148 patients comparing NPH added to a BBI regimen with BBI alone (28-30), the mean daily BG was 40.”
BackgroundTalutis, S. D., Lee, S. Y., Cheng, D., Rosenkranz, P., Alexanian, S. M., & McAneny, D. (2020) · The American Journal of Surgery · doi:10.1016/j.amjsurg.2020.03.032 · Cited by 42 · cited 1×
“Benefits and harms The systematic review identified 1 RCT and 2 non-RCTs to address this question in patients with diabetes (11, 110-112).”
BackgroundLenguerrand, E., Beswick, A. D., Whitehouse, M. R., Wylde, V., & Blom, A. W. (2018) · Acta Orthopaedica · doi:10.1080/17453674.2018.1473327 · Cited by 41 · cited 1×
“00); very low level of certainty] (60-70).”
Off-pump coronary artery bypass grafting for poorly controlled diabetic patients.
Matsuura, K., Imamaki, M., Ishida, A., Shimura, H., Niitsuma, Y., & Miyazaki, M. (2009) · PubMed · Cited by 39
Radhakutty, A., Stranks, J. L., Mangelsdorf, B. L., Drake, S. M., Roberts, G. W., Zimmermann, A. T., Stranks, S. N., Thompson, C. H., & Burt, M. G. (2017) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12859 · Cited by 38 · cited 29×
“No differences were found in 2 other RCTs (19, 32) Engagement, training, and education of nursing personnel Patient education regarding care of the device and how to respond to alarms for high or low BG Purchase of equipment (eg, sensors, transmitters, receivers) Expertise from healthcare professionals knowledgeable i…”
BackgroundInfluentialDrincic, A., Pfeffer, E., Luo, J., & Goldner, W. S. (2017) · Journal of Clinical & Translational Endocrinology · doi:10.1016/j.jcte.2017.03.003 · Cited by 38 · cited 1×
“It has been shown that formally trained diabetes resource nurses who have support from a DCES can decrease hospital readmission rates (49, 55).”
BackgroundSelf-citationMagee, M. F., Khan, N. H., Desale, S., & Nassar, C. M. (2014) · The Diabetes Educator · doi:10.1177/0145721714523684 · Cited by 37 · cited 1×
“Additionally, in the setting of limited availability of educators, alternative approaches may be considered, including the use of tablets or other technologies to deliver standardized education to select patients (56), with the understanding that many patients may have difficulty navigating these devices independently…”
BackgroundLaffin, M. R., Li, S., Brisebois, R., Senior, P. A., & Wang, H. (2018) · World Journal of Surgery · doi:10.1007/s00268-017-4413-9 · Cited by 37 · cited 1×
“Benefits and harms The systematic review identified 1 RCT and 2 non-RCTs to address this question in patients with diabetes (11, 110-112).”
BackgroundLaesser, C. I., Cumming, P., Reber, E., Stanga, Z., Muka, T., & Bally, L. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8070935 · Cited by 36 · cited 2×
“Benefits and harms The systematic review identified 2 systematic reviews, 1 RCT, and 3 non-RCTs that address this question (11, 98, 101-103).”
BackgroundOutcomes of Hospitalized Patients with Glucocorticoid-Induced Hyperglycemia—A Retrospective Analysis
Delfs, N., Struja, T., Gafner, S., Muri, T., Baechli, C., Schüetz, P., Müeller, B., & Blum, C. A. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9124079 · Cited by 35 · cited 1×
“GC-associated hyperglycemia, independent of preexisting diabetes, is associated with increased risk of mortality, cardiovascular events, and infections (27).”
BackgroundSchroeder, J. E., Liebergall, M., Raz, I., Egleston, R., Ben Sussan, G., Peyser, A., & Eldor, R. (2012) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.1217 · Cited by 33
Lamloum, S. M., Mobasher, L. A., Karar, A. H., Basiony, L., Abdallah, T. H., Al-Saleh, A. I., & Al-Shamali, N. A. (2009) · Medical Principles and Practice · doi:10.1159/000235893 · Cited by 33
Kaneko, S., Ueda, Y., & Tahara, Y. (2018) · European Surgical Research · doi:10.1159/000494768 · Cited by 32
Kim, H. J., Shim, J., Youn, Y., Song, J. W., Lee, H., & Kwak, Y. L. (2019) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2019.01.086 · Cited by 32 · cited 5×
“23); very low level of certainty] (61, 64-66, 73, 85).”
InfluentialDungan, K. M., Sagrilla, C., Abdel-Rasoul, M., & Osei, K. (2013) · Diabetes Care · doi:10.2337/dc13-0121 · Cited by 30 · cited 2×
“Hospital LOS between CC and no CC may not differ (very low certainty) (116, 117).”
BackgroundCunningham, D. J., Baumgartner, R. E., Federer, A. E., Richard, M. J., & Mithani, S. K. (2019) · Plastic & Reconstructive Surgery · doi:10.1097/prs.0000000000006023 · Cited by 29
Immediate preoperative hyperglycemia correlates with complications in non-cardiac surgical cases
Dougherty, S. M., Schommer, J., Salinas, J. L., Zilles, B., Belding-Schmitt, M. E., Rogers, W. K., Shibli-Rahhal, A. A., & O'Neill, B. T. (2021) · Journal of Clinical Anesthesia · doi:10.1016/j.jclinane.2021.110375 · Cited by 29 · cited 1×
“Other evidence to decision criteria and considerations Among the studies that evaluated the effect of preoperative BG concentrations on postoperative outcomes (83, 93-96), only 2 provided data on BG concentrations on the day of surgery (95, 96).”
BackgroundTatalovic, M., Lehmann, R., Cheetham, M., Nowak, A., Battegay, E., & Rampini, S. K. (2019) · BMJ Open · doi:10.1136/bmjopen-2019-028914 · Cited by 27 · cited 1×
“• The purpose of this guideline was not to provide comprehensive strategies for selecting doses of insulin treatment of GC-induced hyperglycemia; however, the reader can refer to recently published review papers (39-41) for suggestions regarding insulin dosing adjustments for upward or downward titrations of GC therap…”
BackgroundLevitt, D. L., Spanakis, E. K., Ryan, K. A., & Silver, K. D. (2018) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2017.0250 · Cited by 26 · cited 3×
“However, several reported studies included minority populations in underserved areas, many of whom had chronic kidney disease stages 3 to 5, demonstrating the feasibility of CGM in high-risk populations (15, 17).”
BackgroundStandardized wording to improve efficiency and clarity of GRADE EtD frameworks in health guidelines
Piggott, T., Baldeh, T., Dietl, B., Wiercioch, W., Nieuwlaat, R., Santesso, N. A., Alonso‐Coello, P., & Schünemann, H. J. (2022) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2022.01.004 · Cited by 26 · cited 2×
“Research evidence summaries noted in the EtD frameworks were compiled using standardized terminology templates for clarity and consistency (133).”
MethodSelf-citationKhowaja, A., Alkhaddo, J. B., Rana, Z., & Fish, L. (2018) · Diabetes Therapy · doi:10.1007/s13300-018-0468-3 · Cited by 25 · cited 30×
“Similarly, in a study comparing NPH added to home therapy vs home therapy alone (31), mean daily BG was 42.”
BackgroundInfluentialPilot trial of diabetes self-management education in the hospital setting
Korytkowski, M. T., Koerbel, G. L., Kotagal, L. V., Donihi, A. C., & DiNardo, M. M. (2014) · Primary care diabetes · doi:10.1016/j.pcd.2013.11.008 · Cited by 25 · cited 9×
“• A comprehensive diabetes discharge-planning process includes education on and validation of diabetes survival skills, referral for outpatient DSMES, scheduling diabetes care follow-up appointments, and ensuring access to the medications and supplies required for diabetes self-management following discharge.”
BackgroundInfluentialSelf-citationPatient-Centered Diabetes Care of Cancer Patients
Kotwal, A., Cheung, Y.-M. M., Cromwell, G. E., Drincic, A., Leblebjian, H., Quandt, Z., Rushakoff, R. J., & McDonnell, M. E. (2021) · Current Diabetes Reports · doi:10.1007/s11892-021-01435-y · Cited by 24 · cited 1×
“• The purpose of this guideline was not to provide comprehensive strategies for selecting doses of insulin treatment of GC-induced hyperglycemia; however, the reader can refer to recently published review papers (39-41) for suggestions regarding insulin dosing adjustments for upward or downward titrations of GC therap…”
BackgroundSelf-citationMultivariate analysis of incision infection after posterior lumbar surgery in diabetic patients
Peng, W., Liang, Y., Lü, T., Li, M., Li, D., Du, K.-H., & Wu, J. (2019) · Medicine · doi:10.1097/md.0000000000015935 · Cited by 23
Shin, S., Choi, Y. S., Shin, H. J., Yang, I. H., Park, K. K., Kwon, H. M., Kang, B., & Kim, S. Y. (2020) · Journal of the American Academy of Orthopaedic Surgeons · doi:10.5435/jaaos-d-20-00089 · Cited by 23 · cited 2×
“Benefits and harms The systematic review identified 1 RCT and 2 non-RCTs to address this question in patients with diabetes (11, 110-112).”
BackgroundSpanakis, E. K., Shah, N. G., Malhotra, K., Kemmerer, T., Yeh, H., & Golden, S. H. (2014) · Hospital Practice · doi:10.3810/hp.2014.04.1100 · Cited by 22 · cited 1×
“Patients receiving any type of supraphysiologic GC who are treated with a basal-bolus regimen require a higher percentage of nutritional insulin to achieve normoglycemia (35).”
BackgroundRedesigning Hospital Diabetes Education
Smith, K. M., Baker, K. M., Bardsley, J. K., McCartney, P. R., & Magee, M. F. (2018) · Journal of Nursing Care Quality · doi:10.1097/ncq.0000000000000349 · Cited by 22 · cited 1×
“Additionally, in the setting of limited availability of educators, alternative approaches may be considered, including the use of tablets or other technologies to deliver standardized education to select patients (56), with the understanding that many patients may have difficulty navigating these devices independently…”
BackgroundRamadan, M., Abdelgawad, A., Elshemy, A. M., Sarawy, E., Emad, A., Mazen, M., & Aziz, A. A. (2017) · The Egyptian Heart Journal · doi:10.1016/j.ehj.2017.09.002 · Cited by 19 · cited 6×
“78); very low level of certainty] (60, 61, 6468, 72, 86-88), postoperative renal failure [12 observational (non-RCT) studies: RR 0.”
BackgroundInfluentialMurphy, J. A., Schroeder, M. N., Ridner, A. T., Gregory, M. E., Whitner, J. B., & Hackett, S. G. (2019) · Journal of Pharmacy Practice · doi:10.1177/0897190019833217 · Cited by 19 · cited 18×
“Justification for the recommendation The panel based its recommendation on low-certainty evidence demonstrating similar glycemic outcomes for mean BG, hyperglycemia, hypoglycemia, and hospital LOS with NPHand BBI-based regimens for patients with GC-associated hyperglycemia in the hospital.”
BackgroundInfluentialGerards, M. C., Tervaert, E. C. C., Hoekstra, J. B. L., Vriesendorp, T. M., & Gerdes, V. E. A. (2015) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2015.05.040 · Cited by 18 · cited 1×
“Barriers to addressing GC-associated hyperglycemia may be bridged by establishing protocols and guidelines that outline best practices for achieving and maintaining glycemic control, such as administration of NPH at the same time as intermediate-acting GCs, such as prednisone or methylprednisolone (36-38).”
BackgroundHirose, M., Yamanaka, H., Ishikawa, E., Sai, A., & Kawamura, T. (2011) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2011.05.013 · Cited by 18 · cited 2×
“(117), and 1 found little to no difference in the number of events with CC (118).”
BackgroundEvaluation of the timing and coordination of prandial insulin administration in the hospital
Alwan, D., Chipps, E., Yen, P.-Y., & Dungan, K. (2017) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2017.06.021 · Cited by 18 · cited 1×
“Although most nurses trained in CC report being confident with calculating insulin doses, the opposite is true of administering doses on time (119).”
BackgroundDeo, S. V., Sundaram, V., Sheikh, M. A., Sahadevan, J., Selvaganesan, P., Mohan, S. K. M., Rubelowsky, J. J., Elgudin, Y. E., Josephson, R., Davierwala, P. M., et al. (2021) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezab180 · Cited by 18 · cited 2×
“78); very low level of certainty] (60, 61, 6468, 72, 86-88), postoperative renal failure [12 observational (non-RCT) studies: RR 0.”
BackgroundInpatient Diabetes Education Performed by Staff Nurses Decreases Readmission Rates
Corl, D. E., Guntrum, P. L., Graf, L., Suhr, L. D., Thompson, R., & Wisse, B. E. (2015) · AADE in Practice · doi:10.1177/2325160314568369 · Cited by 17 · cited 19×
“Justification for the recommendation The panel based its recommendation on low-certainty evidence demonstrating similar glycemic outcomes for mean BG, hyperglycemia, hypoglycemia, and hospital LOS with NPHand BBI-based regimens for patients with GC-associated hyperglycemia in the hospital.”
BackgroundInfluentialProactive Protocol-Based Management of Hyperglycemia and Diabetes in Colorectal Surgery Patients
Colibaseanu, D., Osagiede, O., McCoy, R. G., Spaulding, A., Habermann, E. B., Naessens, J. M., Perry, M. F., White, L. J., & Cima, R. R. (2018) · Endocrine Practice · doi:10.4158/ep-2018-0379 · Cited by 17
Enhanced Recovery after Surgery (ERAS®) Outcomes in Patients with Prior Diagnosis of Diabetes
Villamiel, K. M. F., Yao, C., & Sioson, M. S. (2019) · Journal of the ASEAN Federation of Endocrine Societies · doi:10.15605/jafes.034.01.11 · Cited by 17 · cited 2×
“92); very low level of certainty] (62, 65-67, 72, 85).”
Diabetic control and coronary artery bypass: effect on short-term outcomes
Strahan, S., Harvey, R. M., Campbell-Lloyd, A. J. M., Beller, E., Mundy, J. A., & Shah, P. J. (2013) · Asian Cardiovascular and Thoracic Annals · doi:10.1177/0218492312451983 · Cited by 16 · cited 4×
“33); very low level of certainty] (60, 61, 64, 65, 67, 68, 72, 73, 85-87, 89, 91, 92) were also observed.”
BackgroundInfluentialLiu, X., Wu, C.-J. J., Willis, K. F., Shi, Y., & Johnson, M. (2018) · Health Education Research · doi:10.1093/her/cyy023 · Cited by 16 · cited 17×
“Justification for the recommendation The panel based its recommendation on low-certainty evidence demonstrating similar glycemic outcomes for mean BG, hyperglycemia, hypoglycemia, and hospital LOS with NPHand BBI-based regimens for patients with GC-associated hyperglycemia in the hospital.”
BackgroundInfluentialTailakh, M. A., Ishay, S. Y., Awesat, J., Poupko, L., Sahar, G., & Novack, V. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10122739 · Cited by 16 · cited 4×
“33); very low level of certainty] (60, 61, 64, 65, 67, 68, 72, 73, 85-87, 89, 91, 92) were also observed.”
InfluentialViana, M. V., Viana, L. V., Tavares, A. L. J., & de Azevedo, M. J. (2017) · Annals of Nutrition and Metabolism · doi:10.1159/000481355 · Cited by 15 · cited 1×
“Should basal or BBI vs NPH insulin be used for adults hospitalized for noncritical illness receiving enteral nutrition with diabetesspecific and nonspecific formulations? Background Hyperglycemia frequently occurs in hospitalized patients receiving enteral nutrition and is associated with a higher risk of complication…”
BackgroundLuzio, R. D., Dusi, R., Morigi, A., Nicolantonio, D. D., Mittermaier, P., Marchesini, G., & Bianchi, G. P. (2020) · Acta Diabetologica · doi:10.1007/s00592-020-01503-x · Cited by 15 · cited 1×
“Similar findings were observed with observational (non-RCT) studies (125-127).”
ResultSürer, S., Seren, M., Saydam, O., Bulut, A., & Kızıltepe, U. (2016) · Pakistan Journal of Medical Sciences · doi:10.12669/pjms.321.8588 · Cited by 14 · cited 1×
“33); very low level of certainty] (60, 61, 64, 65, 67, 68, 72, 73, 85-87, 89, 91, 92) were also observed.”
Zhuang, T., Shapiro, L. M., Fogel, N., Richard, M. J., Gardner, M. J., & Kamal, R. N. (2021) · The Journal Of Hand Surgery · doi:10.1016/j.jhsa.2021.04.001 · Cited by 14
Arslan, Ü., Memetoğlu, M. E., Kutlu, R., Erbasan, O., Tort, M., Çalık, E. S., Yıldız, Z., Kayğın, M. A., Erdem, O., & Tekin, A. İ. (2015) · Russian Open Medical Journal · doi:10.15275/rusomj.2015.0204 · Cited by 13 · cited 4×
“33); very low level of certainty] (60, 61, 64, 65, 67, 68, 72, 73, 85-87, 89, 91, 92) were also observed.”
InfluentialMedium-term glycemic control in diabetics before coronary bypass surgery.
Santos, J. M., Favaloro, R. R., Lowenstein, D. H., Sanabria, H. D., Raffaelli, H., & Hershson, A. (2015) · PubMed · Cited by 12
Ehara, N., Morimoto, T., Furukawa, Y., Shizuta, S., Taniguchi, R., Nakagawa, Y., Hoshino, K., Saito, N., Doi, T., Haruna, Y., et al. (2010) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2009.11.024 · Cited by 11 · cited 1×
“33); very low level of certainty] (60, 61, 64, 65, 67, 68, 72, 73, 85-87, 89, 91, 92) were also observed.”
Perera, N., Harding, A., Constantino, M., Molyneaux, L. M., McGill, M. J., Chua, E., Twigg, S., Ross, G., & Yue, D. (2011) · Practical Diabetes · doi:10.1002/pdi.1612 · Cited by 11
Thurber, K. M., Dierkhising, R. A., Reiland, S. A., Pearson, K. K., Smith, S. A., & O'Meara, J. G. (2016) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2015.0103 · Cited by 10 · cited 3×
“(117), and 1 found little to no difference in the number of events with CC (118).”
BackgroundSaid, E., Farid, S. F., Sabry, N. A., & Fawzi, M. (2013) · Pharmacology & Pharmacy · doi:10.4236/pp.2013.47080 · Cited by 10
Impact of inpatient diabetes transitions of care consult on glycemic control
Powers, A., Winder, M. B., Maurer, M., & Brittain, K. (2020) · Patient Education and Counseling · doi:10.1016/j.pec.2020.01.010 · Cited by 10 · cited 1×
“Benefits and harms The systematic review identified 4 RCTs and 6 non-RCTs to address this question (11, 45-54).”
BackgroundHijaze, D., & Szalat, A. (2017) · Nutrition in Clinical Practice · doi:10.1177/0884533617692765 · Cited by 9 · cited 1×
“Benefits and harms The systematic review identified 2 systematic reviews, 1 RCT, and 3 non-RCTs that address this question (11, 98, 101-103).”
BackgroundShoghli, M., Jain, R. K., Boroumand, M. A., Ziaee, S., Rafiee, A., Pourgholi, L., Shafiee, A., Jalali, A., Mortazavi, S. H., & Tafti, S. H. A. (2020) · Brazilian Journal of Cardiovascular Surgery · doi:10.21470/1678-9741-2019-0320 · Cited by 8 · cited 1×
“00); very low level of certainty] (60-70).”
Chen, Z., Ding, S.-C., Yuan, Y., Du, J., & Zhang, L. (2020) · BioMed Research International · doi:10.1155/2020/3645374 · Cited by 7 · cited 2×
“33); very low level of certainty] (60, 61, 64, 65, 67, 68, 72, 73, 85-87, 89, 91, 92) were also observed.”
BackgroundPichardo-Lowden, A. R. (2021) · Journal of Diabetes Science and Technology · doi:10.1177/1932296820982661 · Cited by 5
Özmen, R., Tunçay, A., Yılmaz, H., Sari, G., & Taşdemir, H. (2022) · Brazilian Journal of Cardiovascular Surgery · doi:10.21470/1678-9741-2020-0542 · Cited by 3 · cited 2×
“17); very low level of certainty] (60, 61, 64, 66, 67, 69, 72, 73, 86, 8890), and cardiac complications [14 observational (non-RCT) studies: RR 0.”
Research works printed but not linked: 5
- Dhatariya, 2000, Management of diabetes and hyperglycemia in hospitalized patients
- Ali, 2020, Impact of elevated glycosylated haemoglobin on outcomes following CABG in patients with diabetes mellitus, Pakistan J Med Health Sci., 14, 1167
- 2021, Gradepro guideline development tool
- Schünemann, 2013, Grade Handbook.
- Schünemann, 2018, Blood Adv, 3198
Cited by
Blonde, L., Umpierrez, G. E., Reddy, S. S., McGill, J. B., Berga, S. L., Bush, M., Chandrasekaran, S., DeFronzo, R. A., Einhorn, D., Galindo, R. J., et al. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.08.002 · Cited by 507
Self-citation7. Diabetes Technology: Standards of Care in Diabetes—2025
American Diabetes Association Professional Practice Committee, ElSayed, N. A., McCoy, R. G., Aleppo, G., Balapattabi, K., Beverly, E. A., Briggs Early, K., Bruemmer, D., Echouffo-Tcheugui, J. B., Ekhlaspour, L., et al. (2025) · Diabetes Care · doi:10.2337/dc25-s007 · Cited by 348
7. Diabetes Technology: Standards of Care in Diabetes — 2023
ElSayed, N. A., Aleppo, G., Aroda, V. R., Bannuru, R. R., Brown, F. M., Bruemmer, D., Collins, B. S., Hilliard, M. E., Isaacs, D., Johnson, E. L., et al. (2023) · Diabetes Care · doi:10.2337/dc23-s007 · Cited by 301
7. Diabetes Technology: Standards of Care in Diabetes—2024
American Diabetes Association Professional Practice Committee, ElSayed, N. A., Aleppo, G., Bannuru, R. R., Bruemmer, D., Collins, B. S., Ekhlaspour, L., Hilliard, M. E., Johnson, E. L., Khunti, K., et al. (2024) · Diabetes Care · doi:10.2337/dc24-s007 · Cited by 281
16. Diabetes Care in the Hospital: Standards of Care in Diabetes—2023
ElSayed, N. A., Aleppo, G., Aroda, V. R., Bannuru, R. R., Brown, F. M., Bruemmer, D., Collins, B. S., Hilliard, M. E., Isaacs, D., Johnson, E. L., et al. (2023) · Diabetes Care · doi:10.2337/dc23-s016 · Cited by 221
Metadata
- Authors
- Korytkowski, M. T., Muniyappa, R., Antinori-Lent, K., Donihi, A. C., Drincic, A. T., Hirsch, I. B., Luger, A., McDonnell, M. E., Murad, M. H., Nielsen, C., Pegg, C., Rushakoff, R. J., Santesso, N., & Umpierrez, G. E.
- Affiliations
- University of Pittsburgh (US)
- National Institutes of Health (US)
- Shadyside Hospital (US)
- University of Nebraska Medical Center (US)
- University of Washington (US)
- Medical University of Vienna (AT)
- Brigham and Women's Hospital (US)
- Mayo Clinic (US)
- Cleveland Clinic (US)
- Diabetes Patient Advocacy Coalition , Tampa, FL , USA
- University of California, San Francisco (US)
- McMaster University (CA)
- Emory University (US)
- Corresponding author
- Korytkowski, Mary T
- ORCID
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2022-06-12
- Volume
- 107
- Issue
- 8
- Pages
- 2101-2128
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- PMC
- PMC9653018
- OpenAlex
- W4281790366
- Cited by
- 315
- References
- 135
- Citations by year
- 2026: 80 · 2025: 68 · 2024: 78 · 2023: 58 · 2022: 31
- FWCI
- 43.49
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model (vor)
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Endocrine Society
- National Institutes of Health
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- hyperglycemia management, hospitalized patients, diabetes mellitus, non-critically ill patients, stress hyperglycemia, continuous glucose monitoring, insulin pump therapy, prandial insulin, glucocorticoid-induced hyperglycemia, preoperative glycemic control, diabetes self-management education, caloric beverages
- MeSH terms
- Systematic Reviews as Topic, Blood Glucose, Diabetes Mellitus, Humans, Hyperglycemia, Hypoglycemic Agents, Insulin, Blood Glucose Self-Monitoring
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.